Verilumia 
AstraZeneca Discontinues Phase III Lung Cancer Trial
AstraZeneca has discontinued its Phase III eVOLVELung02 clinical trial evaluating the experimental drug volrustomig combined with chemotherapy for metastatic non-small cell lung cancer.
Daiichi Sankyo Company, Limited News
Recent Verilumia coverage about Daiichi Sankyo Company, Limited (4568.T), including reporting-tone insights and market listing information.
